1. Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry 
Paolo Pedrazzoli, Giovanni Martinelli, Alessandro Massimo Gianni, Gian Antonio Da Prada, Alberto Ballestrero, Giovanni Rosti, Giovanni Luca Frassineti, Michele Aieta, Simona Secondino, Saverio Cinieri, Roberta Fedele, Carmelo Bengala, Marco Bregni, Donatella Grasso, Ugo De Giorgi, Francesco Lanza, Luca Castagna, Barbara Bruno, Massimo Martino 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 4, Pages (April 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Kaplan-Meier curves of (A) disease-free survival and (B) overall survival for the whole study population.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Kaplan-Meier estimates of overall survival in prespecified subset analyses. Subsets by (A) menopausal status, (B) tumor hormone-receptor status, (C) tumor size, and (D) number of positive lymph nodes. Survival is calculated in months from time of transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Kaplan-Meier estimates of overall survival. Comparison of multiple versus single high-dose chemotherapy (HDC) and autologous transplantation procedures. (A) Shows the whole study population. (B) Shows patients with ≥ 10 positive lymph nodes.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions